Homepage
Medication Guide
Side effects of Rucaparib
Rucaparib is a PARP inhibitor for the treatment of BRCA mutation-associated ovarian and prostate cancers, with significant efficacy and a variety of side effects, which are described in detail be...
506
Monday, June 23rd, 2025, 15:43
How to alleviate Rucaparib side effects?
Rucaparib is a PARP inhibitor widely used in the treatment of BRCA mutation-associated ovarian and prostate cancers. However, there may be a variety of adverse reactions during its use, such as n...
505
Monday, June 23rd, 2025, 15:29
Instructions for Rucaparib: action and efficacy, dosage, side effects, precautions
Rucaparib is a targeted therapy drug for specific gene mutation-related cancers, mainly used for maintenance therapy of ovarian and prostate cancers. This article will systematically expound the core ...
502
Monday, June 23rd, 2025, 15:16
Rucaparib side effects and precautions
Rucaparib is a PARP inhibitor that is mainly used to treat cancer patients with specific gene mutations. This article will systematically sort out the key information of the drug from three aspects: s...
504
Monday, June 23rd, 2025, 15:01
What are the contraindications to the use of Rucaparib?
Rucaparib is an orally active and potent inhibitor of polyadenosine diphosphate ribose polymerase (PARP). It is suitable for maintenance therapy of BRCA-mutated recurrent ovarian disease and BRCA-muta...
506
Monday, June 23rd, 2025, 14:43
The efficacy of Rucaparib
Rucaparib is a targeted therapy for specific genetic mutation diseases, mainly for BRCA mutation-associated recurrent ovarian disease and metastatic castration-resistant prostate disease. This ar...
508
Monday, June 23rd, 2025, 14:33
The role and efficacy of Rucaparib
Rucaparib is a drug used to treat specific types of diseases, primarily for recurrent ovarian disease and metastatic castration-resistant prostate disease carrying BRCA gene mutations. This artic...
504
Monday, June 23rd, 2025, 14:21
Rucaparib Efficacy, side effects and precautions
Rucaparib, also known as Rubraca, is a PARP inhibitor used to treat BRCA mutation-associated recurrent ovarian lesions and metastatic castration-resistant prostate lesions. It inhibits the activity of...
503
Monday, June 23rd, 2025, 14:00
Guidelines for the administration of Rucaparib
Rucaparib is a targeted therapy drug that targets specific gene mutations and is widely used in the treatment of ovarian and prostate cancer. This article will systematically sort out the core in...
504
Monday, June 23rd, 2025, 13:56
How to use Rucaparib?
Rucaparib is an orally active and potent inhibitor of polyadenosine diphosphate ribose polymerase (PARP). This drug is known for its potent inhibition of PARP1, with a Ki value of 1.4 nM for PARP...
509
Monday, June 23rd, 2025, 13:37
200 / 208
2075 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved